butabarbital decreases consequences of hemin by pharmacodynamic antagonism. Use Warning/Observe. Medicines that boost delta-aminolevulinic acid synthetase may possibly decrease hemin outcome. butabarbital will reduce the level or impact of sufentanil by influencing hepatic/intestinal enzyme CYP3A